LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 46

Search options

  1. Article ; Online: Atherogenesis on the chopping block.

    Gargalovic, Peter S

    Cell metabolism

    2009  Volume 9, Issue 5, Page(s) 399–401

    Abstract: Endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) are now established features of the atherosclerotic plaque. In this issue, Thorp et al. (2009) provide initial insights into the causative relationship between UPR and the ... ...

    Abstract Endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) are now established features of the atherosclerotic plaque. In this issue, Thorp et al. (2009) provide initial insights into the causative relationship between UPR and the atherosclerotic disease process, specifically linking the proapoptotic mediator CHOP to plaque growth and necrosis.
    MeSH term(s) Animals ; Apolipoproteins E/deficiency ; Apolipoproteins E/genetics ; Apoptosis ; Atherosclerosis/metabolism ; Atherosclerosis/pathology ; Cell Line ; Endoplasmic Reticulum/metabolism ; Humans ; Mice ; Mice, Knockout ; RNA, Small Interfering/metabolism ; Receptors, LDL/deficiency ; Receptors, LDL/genetics ; Transcription Factor CHOP/deficiency ; Transcription Factor CHOP/genetics ; Transcription Factor CHOP/metabolism
    Chemical Substances Apolipoproteins E ; DDIT3 protein, human ; Ddit3 protein, mouse ; Lrp4 protein, mouse ; RNA, Small Interfering ; Receptors, LDL ; Transcription Factor CHOP (147336-12-7)
    Language English
    Publishing date 2009-05
    Publishing country United States
    Document type Comment ; Journal Article
    ZDB-ID 2176834-1
    ISSN 1932-7420 ; 1550-4131
    ISSN (online) 1932-7420
    ISSN 1550-4131
    DOI 10.1016/j.cmet.2009.04.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data.

    Jamieson, Michael J / Byon, Wonkyung / Dettloff, Richard W / Crawford, Matthew / Gargalovic, Peter S / Merali, Samira J / Onorato, Joelle / Quintero, Andres J / Russ, Cristina

    American journal of cardiovascular drugs : drugs, devices, and other interventions

    2022  Volume 22, Issue 6, Page(s) 615–631

    Abstract: Relatively little is known about the influence of extreme body weight on the pharmacokinetics (PK), pharmacodynamics (PD), efficacy, and safety of drugs used in many disease states. While direct oral anticoagulants (DOACs) have an advantage over warfarin ...

    Abstract Relatively little is known about the influence of extreme body weight on the pharmacokinetics (PK), pharmacodynamics (PD), efficacy, and safety of drugs used in many disease states. While direct oral anticoagulants (DOACs) have an advantage over warfarin in that they do not require routine drug monitoring, some may regard this convenience as less compelling in obese patients. Some consensus guidelines discourage using DOACs in patients weighing > 120 kg or with a body mass index > 35-40 kg/m
    MeSH term(s) Humans ; Venous Thromboembolism/drug therapy ; Pyridones/adverse effects ; Warfarin/therapeutic use ; Anticoagulants/therapeutic use ; Atrial Fibrillation/drug therapy ; Obesity/complications ; Obesity/drug therapy ; Stroke/epidemiology ; Administration, Oral ; Observational Studies as Topic
    Chemical Substances apixaban (3Z9Y7UWC1J) ; Pyridones ; Warfarin (5Q7ZVV76EI) ; Anticoagulants
    Language English
    Publishing date 2022-05-16
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 2052547-3
    ISSN 1179-187X ; 1175-3277
    ISSN (online) 1179-187X
    ISSN 1175-3277
    DOI 10.1007/s40256-022-00524-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Design and preparation of N-linked hydroxypyridine-based APJ agonists.

    Richter, Jeremy M / Alex Bates, J / Gargalovic, Peter / Onorato, Joelle M / Generaux, Claudia / Wang, Tao / Gordon, David A / Wexler, Ruth R / Finlay, Heather J

    Bioorganic & medicinal chemistry letters

    2022  Volume 73, Page(s) 128882

    Abstract: Agonism of the apelin receptor (APJ) has demonstrated beneficial effects in models of heart failure. We have previously disclosed compounds such as 4, which showed good APJ agonist activity but were metabolized to the mono-demethylated, non- ... ...

    Abstract Agonism of the apelin receptor (APJ) has demonstrated beneficial effects in models of heart failure. We have previously disclosed compounds such as 4, which showed good APJ agonist activity but were metabolized to the mono-demethylated, non-interconverting atropisomer metabolites. Herein, we detail the design and optimization of a novel series of N-linked APJ agonists with good potency, metabolic stability, and rat pharmacokinetic profile, which are unable to undergo the same metabolic mono-demethylation cleavage.
    MeSH term(s) Animals ; Apelin ; Apelin Receptors/agonists ; Pyridines ; Rats ; Receptors, G-Protein-Coupled/agonists
    Chemical Substances Apelin ; Apelin Receptors ; Pyridines ; Receptors, G-Protein-Coupled ; hydroxypyridines
    Language English
    Publishing date 2022-07-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2022.128882
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Identification of a Hydroxypyrimidinone Compound (

    Meng, Wei / Pi, Zulan / Brigance, Robert / Rossi, Karen A / Schumacher, William A / Bostwick, Jeffrey S / Gargalovic, Peter S / Onorato, Joelle M / Luk, Chiuwa E / Generaux, Claudia N / Wang, Tao / Wexler, Ruth R / Finlay, Heather J

    Journal of medicinal chemistry

    2021  Volume 64, Issue 24, Page(s) 18102–18113

    Abstract: This paper describes our continued efforts in the area of small-molecule apelin receptor agonists. Recently disclosed ... ...

    Abstract This paper describes our continued efforts in the area of small-molecule apelin receptor agonists. Recently disclosed compound
    MeSH term(s) Animals ; Apelin Receptors/agonists ; Dogs ; Drug Discovery ; Heart Failure/drug therapy ; Humans ; Pyrimidinones/chemistry ; Pyrimidinones/pharmacokinetics ; Pyrimidinones/pharmacology ; Pyrimidinones/therapeutic use ; Rats ; Structure-Activity Relationship
    Chemical Substances APLNR protein, human ; Apelin Receptors ; Pyrimidinones
    Language English
    Publishing date 2021-12-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.1c01504
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Identification of 6-hydroxy-5-phenyl sulfonylpyrimidin-4(1H)-one APJ receptor agonists.

    Tora, George / Jiang, Ji / Bostwick, Jeffrey S / Gargalovic, Peter S / Onorato, Joelle M / Luk, Chiuwa E / Generaux, Claudia / Xu, Carrie / Galella, Michael A / Wang, Tao / He, Yan / Wexler, Ruth R / Finlay, Heather J

    Bioorganic & medicinal chemistry letters

    2021  Volume 50, Page(s) 128325

    Abstract: Heart failure (HF) treatment remains a critical unmet medical need. Studies in normal healthy volunteers and HF patients have shown that [ ... ...

    Abstract Heart failure (HF) treatment remains a critical unmet medical need. Studies in normal healthy volunteers and HF patients have shown that [Pyr
    MeSH term(s) Animals ; Apelin Receptors/agonists ; Area Under Curve ; Cardiovascular Agents/chemical synthesis ; Cardiovascular Agents/pharmacokinetics ; Cardiovascular Agents/pharmacology ; Drug Design ; Half-Life ; Humans ; Intercellular Signaling Peptides and Proteins/chemistry ; Intercellular Signaling Peptides and Proteins/pharmacology ; Macaca fascicularis ; Molecular Structure ; Pyrimidinones/chemistry ; Pyrimidinones/pharmacology ; Rats ; Structure-Activity Relationship
    Chemical Substances APLNR protein, human ; Apelin Receptors ; Cardiovascular Agents ; Intercellular Signaling Peptides and Proteins ; Pyrimidinones ; apelin 13, Pyr(1)-
    Language English
    Publishing date 2021-08-14
    Publishing country England
    Document type Journal Article
    ZDB-ID 1063195-1
    ISSN 1464-3405 ; 0960-894X
    ISSN (online) 1464-3405
    ISSN 0960-894X
    DOI 10.1016/j.bmcl.2021.128325
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Identification of 6-Hydroxypyrimidin-4(1

    Pi, Zulan / Johnson, James A / Meng, Wei / Phillips, Monique / Schumacher, William A / Bostwick, Jeffrey S / Gargalovic, Peter S / Onorato, Joelle M / Generaux, Claudia N / Wang, Tao / He, Yan / Gordon, David A / Wexler, Ruth R / Finlay, Heather J

    ACS medicinal chemistry letters

    2021  Volume 12, Issue 11, Page(s) 1766–1772

    Abstract: The apelin receptor (APJ) is a significant regulator of cardiovascular function and is involved in heart failure and other cardiovascular diseases. ( ... ...

    Abstract The apelin receptor (APJ) is a significant regulator of cardiovascular function and is involved in heart failure and other cardiovascular diseases. (Pyr
    Language English
    Publishing date 2021-10-22
    Publishing country United States
    Document type Journal Article
    ISSN 1948-5875
    ISSN 1948-5875
    DOI 10.1021/acsmedchemlett.1c00385
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.

    Gargalovic, Peter / Wong, Pancras / Onorato, Joelle / Finlay, Heather / Wang, Tao / Yan, Mujing / Crain, Earl / St-Onge, Stéphane / Héroux, Madeleine / Bouvier, Michel / Xu, Carrie / Chen, Xue-Qing / Generaux, Claudia / Lawrence, Michael / Wexler, Ruth / Gordon, David

    Circulation. Heart failure

    2021  Volume 14, Issue 3, Page(s) e007351

    Abstract: Background: New heart failure therapies that safely augment cardiac contractility and output are needed. Previous apelin peptide studies have highlighted the potential for APJ (apelin receptor) agonism to enhance cardiac function in heart failure. ... ...

    Abstract Background: New heart failure therapies that safely augment cardiac contractility and output are needed. Previous apelin peptide studies have highlighted the potential for APJ (apelin receptor) agonism to enhance cardiac function in heart failure. However, apelin's short half-life limits its therapeutic utility. Here, we describe the preclinical characterization of a novel, orally bioavailable APJ agonist, BMS-986224.
    Methods: BMS-986224 pharmacology was compared with (Pyr
    Results: BMS-986224 was a potent (Kd=0.3 nmol/L) and selective APJ agonist, exhibiting similar receptor binding and signaling profile to (Pyr
    Conclusions: We identify a novel, potent, and orally bioavailable nonpeptidic APJ agonist that closely recapitulates the signaling properties of (Pyr
    Language English
    Publishing date 2021-03-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2429459-7
    ISSN 1941-3297 ; 1941-3289
    ISSN (online) 1941-3297
    ISSN 1941-3289
    DOI 10.1161/CIRCHEARTFAILURE.120.007351
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate.

    Johnson, James A / Kim, Soong-Hoon / Jiang, Ji / Phillips, Monique / Schumacher, William A / Bostwick, Jeffrey S / Gargalovic, Peter S / Onorato, Joelle M / Luk, Chiuwa E / Generaux, Claudia / He, Yan / Chen, Xue-Qing / Xu, Carrie / Galella, Michael A / Wang, Tao / Gordon, David A / Wexler, Ruth R / Finlay, Heather J

    Journal of medicinal chemistry

    2021  Volume 64, Issue 6, Page(s) 3086–3099

    Abstract: Apelin-13 is an endogenous peptidic agonist of the apelin receptor (APJ) receptor with the potential for improving cardiac function in heart failure patients. However, the low plasma stability of apelin-13 necessitates continuous intravenous infusion for ...

    Abstract Apelin-13 is an endogenous peptidic agonist of the apelin receptor (APJ) receptor with the potential for improving cardiac function in heart failure patients. However, the low plasma stability of apelin-13 necessitates continuous intravenous infusion for therapeutic use. There are several approaches to increase the stability of apelin-13 including attachment of pharmacokinetic enhancing groups, stabilized peptides, and Fc-fusion approaches. We sought a small-molecule APJ receptor agonist approach to target a compound with a pharmacokinetic profile amenable for chronic oral administration. This manuscript describes sequential optimization of the pyrimidinone series, leading to pyridinone
    MeSH term(s) Animals ; Apelin Receptors/agonists ; Apelin Receptors/metabolism ; Dogs ; Drug Discovery ; Haplorhini ; Humans ; Intercellular Signaling Peptides and Proteins/metabolism ; Male ; Models, Molecular ; Pyridones/chemistry ; Pyridones/pharmacokinetics ; Pyridones/pharmacology ; Rats ; Rats, Sprague-Dawley
    Chemical Substances Apelin Receptors ; Intercellular Signaling Peptides and Proteins ; Pyridones ; apelin-13 peptide
    Language English
    Publishing date 2021-03-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.0c01878
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Caveolins and macrophage lipid metabolism.

    Gargalovic, Peter / Dory, Ladislav

    Journal of lipid research

    2003  Volume 44, Issue 1, Page(s) 11–21

    Abstract: The identification of caveolin-1 more than a decade ago initiated active research into its role in the formation of caveolae, membrane trafficking, signal transduction pathways, and lipid homeostasis. Although caveolins are ubiquitously expressed, the ... ...

    Abstract The identification of caveolin-1 more than a decade ago initiated active research into its role in the formation of caveolae, membrane trafficking, signal transduction pathways, and lipid homeostasis. Although caveolins are ubiquitously expressed, the majority of the available information comes from differentiated cells rich in caveolins, such as fibroblasts, adipocytes, and endothelial cells. During the development of atherosclerosis, macrophages play a pivotal role in the formation of the fatty streak lesions. They take up large amounts of lipids and accumulate in the subendothelial space, forming foam cells that fill up the lesion area. Since caveolins have been implicated in the regulation of cellular cholesterol metabolism in several cell types, it is of interest to examine their potential function in macrophages. In this review, we attempt to summarize current knowledge and views on the role of caveolins in cholesterol metabolism with emphasis on macrophages.
    MeSH term(s) Animals ; Caveolae/metabolism ; Caveolins/genetics ; Caveolins/metabolism ; Cholesterol/metabolism ; Gene Expression Regulation ; Humans ; Lipid Metabolism ; Macrophages/cytology ; Macrophages/metabolism
    Chemical Substances Caveolins ; Cholesterol (97C5T2UQ7J)
    Language English
    Publishing date 2003-01
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 80154-9
    ISSN 1539-7262 ; 0022-2275
    ISSN (online) 1539-7262
    ISSN 0022-2275
    DOI 10.1194/jlr.r200005-jlr200
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Cellular apoptosis is associated with increased caveolin-1 expression in macrophages.

    Gargalovic, Peter / Dory, Ladislav

    Journal of lipid research

    2003  Volume 44, Issue 9, Page(s) 1622–1632

    Abstract: Macrophage apoptosis is an important factor in determining the efficiency of the immune response, atherosclerotic lesion stability, and clearance of aged cells by phagocytosis. The involvement of caveolin-1 in the regulation of apoptosis has been ... ...

    Abstract Macrophage apoptosis is an important factor in determining the efficiency of the immune response, atherosclerotic lesion stability, and clearance of aged cells by phagocytosis. The involvement of caveolin-1 in the regulation of apoptosis has been previously suggested in fibroblasts and epithelial cells. Here we show that treatment of thioglycollate-elicited mouse peritoneal macrophages with various unrelated apoptotic agents, including simvastatin, camptothecin, or glucose deprivation, is associated with a specific and large increase in caveolin-1 expression. In contrast, caveolin-2 levels remain unaffected. Induction of apoptosis was measured by changes in cell morphology, annexin V-labeling, and DNA fragmentation. We demonstrate that caveolin-1 in macrophages is present in lipid rafts and colocalizes with phosphatidylserine (PS) at the cell surface of apoptotic macrophages. Our data suggest that caveolin-1 increase is an early event, closely accompanied by PS externalization and independent of caspase activation and nuclear DNA fragmentation. The increase in caveolin-1 levels does not require new protein synthesis, as cycloheximide does not prevent the apoptosis-mediated increase in caveolin-1 levels. We propose that increased levels of caveolin-1 characterize the apoptotic phenotype of macrophages. Caveolin-1 may be involved in the efficient externalization of PS at the surface of the apoptotic cells.
    MeSH term(s) Animals ; Apoptosis/drug effects ; Apoptosis/physiology ; Caspases/metabolism ; Caveolin 1 ; Caveolin 2 ; Caveolins/genetics ; Caveolins/metabolism ; Cells, Cultured ; Enzyme Activation ; Gene Expression Regulation/drug effects ; Macrophages/cytology ; Macrophages/drug effects ; Macrophages/enzymology ; Macrophages/metabolism ; Membrane Microdomains/metabolism ; Mice ; Protein Biosynthesis ; Simvastatin/pharmacology ; Up-Regulation
    Chemical Substances Cav1 protein, mouse ; Caveolin 1 ; Caveolin 2 ; Caveolins ; Simvastatin (AGG2FN16EV) ; Caspases (EC 3.4.22.-)
    Language English
    Publishing date 2003-06-01
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 80154-9
    ISSN 1539-7262 ; 0022-2275
    ISSN (online) 1539-7262
    ISSN 0022-2275
    DOI 10.1194/jlr.M300140-JLR200
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top